Mason Street Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Mason Street Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-78,230	Closed	-$2.21M	–	1796
2014 Q4	$2.21M	Hold	78,230	–	–	0.02%	912
2014 Q3	$1.98M	Hold	78,230	–	–	0.02%	947
2014 Q2	$2.28M	Sell	78,230 -16,450	-17%	-$398K	0.02%	897
2014 Q1	$2.45M	Buy	94,680 +26,180	+38%	+$699K	0.02%	844
2013 Q4	$1.76M	Buy	+68,500	New	+$1.66M	0.01%	992

Other funds holding PTLA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Mason Street Advisors's PTLA Position: Q1 2015 in Review

Mason Street Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2015, closing a stake of 78,230 shares — an estimated $2.21M sold.

Mason Street Advisors first reported a position in PTLA in Q4 2013 and held it in 5 quarters. The position peaked at $2.45M in Q1 2014. 160 funds tracked by Wall St. Rank hold PTLA as of Q1 2015.

Mason Street Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 78,230 Portola Pharmaceuticals, Inc. shares in Q1 2015, an estimated $2.21M.
Mason Street Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
Mason Street Advisors's Portola Pharmaceuticals, Inc. position peaked at $2.45M in Q1 2014.
160 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.